Genmab A/S (GMAB)
Nasdaq: GMAB · Pharmaceutical Preparations · 1253 Copenhagen K, DK · filing with the SEC since 2008
Income statement, as filed
In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Feb 17, 2026 | Feb 12, 2025 | Feb 14, 2024 | Feb 22, 2023 |
| Revenue | 3,720 | 3,121 | 2,390 | · |
| Cost of revenue | 238 | 143 | 33 | · |
| Research and development | 1,606 | 1,414 | 1,107 | · |
| Selling, general and administrative | 626 | 549 | 478 | · |
| Total operating expenses | 2,655 | 2,149 | 1,618 | · |
| Operating income | 1,065 | 972 | 772 | · |
| Finance costs | 269 | 291 | 254 | · |
| Finance income | 408 | 645 | 299 | · |
| Net finance income (costs) | 139 | 354 | 45 | · |
| Income before income taxes | 1,204 | 1,326 | 817 | · |
| Income tax expense | 241 | 193 | 186 | · |
| Net income | 963 | 1,133 | 631 | · |
| Earnings per share, basic | 15.50 | 17.66 | 9.67 | · |
| Earnings per share, diluted | 15.37 | 17.53 | 9.58 | · |
| Weighted average shares, basic | 64,721,175 | 66,139,029 | 66,023,437 | · |
| Weighted average shares, diluted | 62,691,630 | 64,655,986 | 65,897,577 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
ifrs-full:RevenueCost of revenue what it cost to make or buy what it sold
ifrs-full:CostOfSalesResearch and development spent on inventing what it sells next
ifrs-full:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
ifrs-full:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
ifrs-full:OperatingExpenseOperating income profit from running the business, before interest and tax
ifrs-full:ProfitLossFromOperatingActivitiesFinance costs what its borrowing cost
ifrs-full:FinanceCostsFinance income what its cash and investments earned
ifrs-full:FinanceIncomeNet finance income (costs) interest earned less interest paid, outside the business
ifrs-full:FinanceIncomeCostIncome before income taxes profit before tax
ifrs-full:ProfitLossBeforeTaxIncome tax expense tax charged on the period's profit
ifrs-full:IncomeTaxExpenseContinuingOperationsNet income the whole group's profit, minority holders' share included
ifrs-full:ProfitLossEarnings per share, basic net income per share outstanding
ifrs-full:BasicEarningsLossPerShareEarnings per share, diluted net income per share, counting every share that could be issued
ifrs-full:DilutedEarningsLossPerShareWeighted average shares, basic the average count of shares outstanding
ifrs-full:WeightedAverageSharesWeighted average shares, diluted the average count with every share that could be issued
ifrs-full:AdjustedWeightedAverageShares